CuraScript SD competitors

Mark L. Baum is the founder and CEO of Imprimis Pharmaceuticals whose mission is to provide patients and physicians with innovative and affordable ophthalmic drugs in the ocular surgery, glaucoma, and dry eye disease markets. He is also a founder and board member of Eton Pharmaceuticals and Surface Pharmaceuticals, as well as a board member and chairman of the audit committee of Ideal Power. He was named by Ernst & Young LLP as the 2017 Entrepreneur of the Year™ in the life sciences category for the San Diego region. Prior to Imprimis, as the founder of TBLF, LLC, a private investment fund, He made more than 200 investments into more than 40 private and public companies. In 1999, He founded YesRx, an HIV-focused pharmacy business. He's advocacy for drug pricing and accessibility issues has been reflected as an Op-Ed contributor for the Wall Street Journal and through appearances on CBS, CNN, MSNBC, Fox Business, Bloomberg and Al Jazeera. He is a 1995 cum laude graduate of The University of Texas at Arlington and a 1997 graduate of California Western School of Law.

Mr. Luis E. Dini is a Chairman - Chief Executive Officer at Home Solutions and is based in United States.

Michael Gavin is a President/CEO at IWP (Injured Workers Pharmacy) and is based in Atlanta, Georgia. He has worked as Senior Manager at Kurt Salmon, VP of Operations at SPH Analytics, and Consultant at Monitor Group. Michael works or has worked as VP:Operations at MDdatacor and President at PRIUM. He studied at Emory University between 2006 and 2007, Emory University - Goizueta Business School between 2006 and 2007, and Georgetown McDonough School of Business between 1997 and 2000.

Michael Fieri joined Orsini Healthcare as Founder and Chief Executive Officer at Michael attended Quinlan School of Business, Loyola University Chicago.

Arcilia C. Acosta is a President & Chief Executive Officer at DOUGHERTY S PHARMACY INC. and is based in Legacytexas Financial Group Inc.